Figure 1From: Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropiumDifferences in trough forced expiratory volume in 1 second (FEV 1 ) between tiotropium and placebo in INHANCE[9]and studies in which tiotropium was the primary treatment of investigation. Values are means and standard errors. *Includes assessments made at 11, 12 and 13 weeks; †Includes assessments made at 25 weeks; ‡Estimated from a figure (no standard error available); #No standard error available.Back to article page